Aperio Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$46.3M Sell
3,249,795
-326,480
-9% -$4.65M 0.14% 141
2020
Q3
$49.8M Sell
3,576,275
-214,995
-6% -$2.99M 0.17% 112
2020
Q2
$40.2M Sell
3,791,270
-302,295
-7% -$3.2M 0.15% 132
2020
Q1
$33M Buy
4,093,565
+374,710
+10% +$3.02M 0.15% 147
2019
Q4
$30.2M Buy
3,718,855
+733,150
+25% +$5.95M 0.11% 204
2019
Q3
$22.6M Buy
2,985,705
+477,385
+19% +$3.62M 0.09% 264
2019
Q2
$18.8M Buy
2,508,320
+541,420
+28% +$4.06M 0.08% 296
2019
Q1
$15.9M Buy
1,966,900
+429,150
+28% +$3.48M 0.07% 320
2018
Q4
$11.6M Buy
1,537,750
+356,160
+30% +$2.69M 0.06% 360
2018
Q3
$8.18M Buy
1,181,590
+128,365
+12% +$888K 0.04% 509
2018
Q2
$6.78M Buy
1,053,225
+224,405
+27% +$1.45M 0.03% 563
2018
Q1
$5.42M Sell
828,820
-94,810
-10% -$620K 0.03% 622
2017
Q4
$6.94M Buy
923,630
+13,760
+2% +$103K 0.04% 525
2017
Q3
$6.49M Buy
909,870
+92,295
+11% +$659K 0.04% 514
2017
Q2
$6.89M Buy
817,575
+83,670
+11% +$705K 0.04% 484
2017
Q1
$5.89M Buy
733,905
+69,855
+11% +$561K 0.04% 489
2016
Q4
$6.01M Sell
664,050
-113,540
-15% -$1.03M 0.05% 442
2016
Q3
$7.22M Sell
777,590
-6,255
-0.8% -$58.1K 0.05% 418
2016
Q2
$8.03M Buy
783,845
+32,665
+4% +$335K 0.06% 351
2016
Q1
$6.79M Buy
751,180
+113,640
+18% +$1.03M 0.06% 381
2015
Q4
$5.9M Sell
637,540
-149,955
-19% -$1.39M 0.05% 404
2015
Q3
$10.1M Buy
787,495
+63,525
+9% +$812K 0.1% 232
2015
Q2
$8.01M Buy
723,970
+57,240
+9% +$633K 0.08% 291
2015
Q1
$7.61M Buy
666,730
+42,080
+7% +$481K 0.09% 295
2014
Q4
$6.3M Buy
624,650
+13,540
+2% +$137K 0.08% 315
2014
Q3
$6.42M Buy
611,110
+6,125
+1% +$64.4K 0.09% 286
2014
Q2
$5.22M Sell
604,985
-14,270
-2% -$123K 0.08% 320
2014
Q1
$5.44M Buy
+619,255
New +$5.44M 0.08% 331
2013
Q4
Sell
-479,215
Closed -$3.62M 341
2013
Q3
$3.62M Buy
479,215
+22,815
+5% +$172K 0.07% 367
2013
Q2
$3.45M Buy
+456,400
New +$3.45M 0.08% 305